legal-document-to-plain-english-translator/”>Try Free Now: Legalese tool without registration

Find a LOCAL lawyer

## Cellectis Inc. Announces Financial Results for First Quarter 2024

Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, has announced that it will report financial results for the first quarter 2024 ending March 31, 2024 on Tuesday, May 28, 2024 after the close of the US market.

The publication will be followed by an investor conference call and webcast on Wednesday, May 29, 2024 at 8:00 AM ET / 2:00 PM CET. The call will include the Company’s first quarter results and an update on business activities.

**Dial in information:**
Domestic: 1-877-451-6152
International: 1-201-389-0879
Conference ID: 13746795
Webcast Link: [https://viavid.webcasts.com/starthere.jsp?ei=1672725&tp_key=f83e7ab481](https://viavid.webcasts.com/starthere.jsp?ei=1672725&tp_key=f83e7ab481)

### About Cellectis

Cellectis is a clinical-stage biotechnology company utilizing its gene-editing platform to develop life-saving cell and gene therapies. Cellectis employs an allogeneic approach for CAR-T immunotherapies in oncology and utilizes a platform to make therapeutic gene editing in hemopoietic stem cells for various diseases. As a clinical-stage biopharmaceutical company with over 24 years of experience in gene editing, Cellectis is developing product candidates using TALEN®, its gene editing technology, and PulseAgile, its pioneering electroporation system. The company’s headquarters are in Paris, France, with locations in New York, New York, and Raleigh, North Carolina.

### How AI legalese decoder Can Help

The AI legalese decoder can be incredibly beneficial in analyzing and deciphering complicated legal language that may be present in financial reports or regulatory filings. By using AI technology, individuals can quickly and accurately understand the implications of legal terms and clauses, helping them make informed decisions. In the context of Cellectis Inc.’s financial results announcement, the AI legalese decoder can assist in interpreting any legal jargon or complex language related to the company’s financial performance and regulatory compliance. This tool can streamline the process of understanding legal documents, enabling stakeholders to grasp important information more efficiently.

legal-document-to-plain-english-translator/”>Try Free Now: Legalese tool without registration

Find a LOCAL lawyer

Reference link